Annual EBIT
$36.00 M
+$23.95 M+198.81%
31 December 2023
Summary:
Puma Biotechnology annual earnings before interest & taxes is currently $36.00 million, with the most recent change of +$23.95 million (+198.81%) on 31 December 2023. During the last 3 years, it has risen by +$52.00 million (+325.10%). PBYI annual EBIT is now at all-time high.PBYI EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$23.71 M
+$24.49 M+3143.39%
30 September 2024
Summary:
Puma Biotechnology quarterly earnings before interest & taxes is currently $23.71 million, with the most recent change of +$24.49 million (+3143.39%) on 30 September 2024. Over the past year, it has increased by +$7.55 million (+46.73%). PBYI quarterly EBIT is now at all-time high.PBYI Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
$37.85 M
+$14.36 M+61.13%
30 September 2024
Summary:
Puma Biotechnology TTM earnings before interest & taxes is currently $37.85 million, with the most recent change of +$14.36 million (+61.13%) on 30 September 2024. Over the past year, it has increased by +$1.85 million (+5.13%). PBYI TTM EBIT is now at all-time high.PBYI TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PBYI EBIT Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | +46.7% | +5.1% |
3 y3 years | +325.1% | +231.4% | +338.1% |
5 y5 years | +159.5% | +393.8% | +162.5% |
PBYI EBIT High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +325.1% | at high | +1266.2% | at high | +203.4% |
5 y | 5 years | at high | +159.5% | at high | +157.1% | at high | +155.1% |
alltime | all time | at high | +112.4% | at high | +130.5% | at high | +112.6% |
Puma Biotechnology EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $23.71 M(-3143.4%) | $37.85 M(+61.1%) |
June 2024 | - | -$779.00 K(-37.0%) | $23.49 M(-21.5%) |
Mar 2024 | - | -$1.24 M(-107.6%) | $29.91 M(-16.9%) |
Dec 2023 | $36.00 M(+198.8%) | $16.16 M(+72.8%) | $36.00 M(+102.1%) |
Sept 2023 | - | $9.35 M(+65.8%) | $17.81 M(+60.2%) |
June 2023 | - | $5.64 M(+16.0%) | $11.12 M(-36.9%) |
Mar 2023 | - | $4.86 M(-339.1%) | $17.61 M(+46.2%) |
Dec 2022 | $12.05 M(-175.3%) | -$2.03 M(-176.6%) | $12.05 M(-43.3%) |
Sept 2022 | - | $2.65 M(-78.1%) | $21.24 M(-192.6%) |
June 2022 | - | $12.13 M(-1827.9%) | -$22.93 M(-37.4%) |
Mar 2022 | - | -$702.00 K(-109.8%) | -$36.61 M(+130.4%) |
Dec 2021 | -$15.99 M(-65.0%) | $7.15 M(-117.2%) | -$15.89 M(-53.6%) |
Sept 2021 | - | -$41.51 M(+2578.3%) | -$34.27 M(+66.4%) |
June 2021 | - | -$1.55 M(-107.7%) | -$20.59 M(+73.6%) |
Mar 2021 | - | $20.02 M(-278.4%) | -$11.86 M(-74.1%) |
Dec 2020 | -$45.74 M(-24.4%) | -$11.22 M(-59.7%) | -$45.74 M(+7.4%) |
Sept 2020 | - | -$27.84 M(-487.7%) | -$42.59 M(+49.0%) |
June 2020 | - | $7.18 M(-151.8%) | -$28.59 M(-58.4%) |
Mar 2020 | - | -$13.87 M(+71.8%) | -$68.74 M(+13.6%) |
Dec 2019 | -$60.52 M(-41.0%) | -$8.07 M(-41.7%) | -$60.52 M(-23.7%) |
Sept 2019 | - | -$13.83 M(-58.1%) | -$79.31 M(+4.1%) |
June 2019 | - | -$32.98 M(+484.3%) | -$76.18 M(-10.3%) |
Mar 2019 | - | -$5.64 M(-79.0%) | -$84.95 M(-17.2%) |
Dec 2018 | -$102.57 M(-64.8%) | -$26.86 M(+151.0%) | -$102.57 M(-26.2%) |
Sept 2018 | - | -$10.70 M(-74.4%) | -$139.07 M(-32.3%) |
June 2018 | - | -$41.75 M(+79.4%) | -$205.55 M(-14.9%) |
Mar 2018 | - | -$23.27 M(-63.3%) | -$241.64 M(-17.0%) |
Dec 2017 | -$291.24 M(+5.5%) | -$63.36 M(-17.9%) | -$291.24 M(-3.0%) |
Sept 2017 | - | -$77.18 M(-0.8%) | -$300.16 M(+3.9%) |
June 2017 | - | -$77.83 M(+6.8%) | -$288.98 M(+4.1%) |
Mar 2017 | - | -$72.86 M(+0.8%) | -$277.63 M(+0.6%) |
Dec 2016 | -$276.01 M | -$72.28 M(+9.5%) | -$276.01 M(+4.2%) |
Sept 2016 | - | -$66.00 M(-0.7%) | -$264.76 M(+2.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2016 | - | -$66.48 M(-6.7%) | -$259.50 M(+0.6%) |
Mar 2016 | - | -$71.25 M(+16.7%) | -$257.93 M(+7.8%) |
Dec 2015 | -$239.28 M(+68.2%) | -$61.04 M(+0.5%) | -$239.28 M(+6.0%) |
Sept 2015 | - | -$60.73 M(-6.4%) | -$225.84 M(+12.3%) |
June 2015 | - | -$64.91 M(+23.4%) | -$201.06 M(+14.9%) |
Mar 2015 | - | -$52.60 M(+10.5%) | -$175.06 M(+23.0%) |
Dec 2014 | -$142.28 M(+159.5%) | -$47.59 M(+32.4%) | -$142.28 M(+28.6%) |
Sept 2014 | - | -$35.96 M(-7.6%) | -$110.67 M(+24.3%) |
June 2014 | - | -$38.91 M(+96.3%) | -$89.04 M(+41.7%) |
Mar 2014 | - | -$19.82 M(+24.0%) | -$62.85 M(+14.6%) |
Dec 2013 | -$54.83 M(-26.3%) | -$15.99 M(+11.6%) | -$54.83 M(-9.8%) |
Sept 2013 | - | -$14.33 M(+12.8%) | -$60.79 M(-16.0%) |
June 2013 | - | -$12.71 M(+7.6%) | -$72.33 M(-2.8%) |
Mar 2013 | - | -$11.81 M(-46.2%) | -$74.40 M(-0.1%) |
Dec 2012 | -$74.45 M(+633.0%) | -$21.95 M(-15.2%) | -$74.45 M(+19.5%) |
Sept 2012 | - | -$25.87 M(+75.1%) | -$62.29 M(+69.5%) |
June 2012 | - | -$14.78 M(+24.7%) | -$36.75 M(+67.0%) |
Mar 2012 | - | -$11.85 M(+21.1%) | -$22.01 M(+116.6%) |
Dec 2011 | -$10.16 M(>+9900.0%) | -$9.78 M(+2830.5%) | -$10.16 M(+2654.1%) |
Sept 2011 | - | -$333.90 K(+873.5%) | -$368.80 K(+868.0%) |
June 2011 | - | -$34.30 K(+779.5%) | -$38.10 K(+514.5%) |
Mar 2011 | - | -$3900.00(-218.2%) | -$6200.00(-11.4%) |
Dec 2010 | -$7000.00(-58.3%) | $3300.00(-203.1%) | -$7000.00(-48.5%) |
Sept 2010 | - | -$3200.00(+33.3%) | -$13.60 K(-0.7%) |
June 2010 | - | -$2400.00(-48.9%) | -$13.70 K(-11.6%) |
Mar 2010 | - | -$4700.00(+42.4%) | -$15.50 K(-7.7%) |
Dec 2009 | -$16.80 K(+19.1%) | -$3300.00(0.0%) | -$16.80 K(+7.0%) |
Sept 2009 | - | -$3300.00(-21.4%) | -$15.70 K(-4.3%) |
June 2009 | - | -$4200.00(-30.0%) | -$16.40 K(+5.1%) |
Mar 2009 | - | -$6000.00(+172.7%) | -$15.60 K(+10.6%) |
Dec 2008 | -$14.10 K | -$2200.00(-45.0%) | -$14.10 K(+18.5%) |
Sept 2008 | - | -$4000.00(+17.6%) | -$11.90 K(+50.6%) |
June 2008 | - | -$3400.00(-24.4%) | -$7900.00(+75.6%) |
Mar 2008 | - | -$4500.00 | -$4500.00 |
FAQ
- What is Puma Biotechnology annual earnings before interest & taxes?
- What is the all time high annual EBIT for Puma Biotechnology?
- What is Puma Biotechnology quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Puma Biotechnology?
- What is Puma Biotechnology quarterly EBIT year-on-year change?
- What is Puma Biotechnology TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Puma Biotechnology?
- What is Puma Biotechnology TTM EBIT year-on-year change?
What is Puma Biotechnology annual earnings before interest & taxes?
The current annual EBIT of PBYI is $36.00 M
What is the all time high annual EBIT for Puma Biotechnology?
Puma Biotechnology all-time high annual earnings before interest & taxes is $47.52 M
What is Puma Biotechnology quarterly earnings before interest & taxes?
The current quarterly EBIT of PBYI is $23.71 M
What is the all time high quarterly EBIT for Puma Biotechnology?
Puma Biotechnology all-time high quarterly earnings before interest & taxes is $23.71 M
What is Puma Biotechnology quarterly EBIT year-on-year change?
Over the past year, PBYI quarterly earnings before interest & taxes has changed by +$7.55 M (+46.73%)
What is Puma Biotechnology TTM earnings before interest & taxes?
The current TTM EBIT of PBYI is $37.85 M
What is the all time high TTM EBIT for Puma Biotechnology?
Puma Biotechnology all-time high TTM earnings before interest & taxes is $37.85 M
What is Puma Biotechnology TTM EBIT year-on-year change?
Over the past year, PBYI TTM earnings before interest & taxes has changed by +$1.85 M (+5.13%)